A conference focused on advancements in HIV treatment and research.
Official title: HIV-DART 2024
Funded at Emory University · NIH-11085342 · Data updated 2026-11-12
This study is all about a friendly conference where doctors and researchers come together every two years to share the newest ideas and treatments for HIV and AIDS, while also helping young scientists and supporting diverse voices in the field.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | November 8, 2024 |
| Project end | October 31, 2025 |
| Funding year | 2025 |
| Award (this year) | $30,000 |
| NIH project number | 1R13AI189261-01 |
| Project ID | NIH-11085342 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation include healthcare professionals, researchers, and students interested in HIV treatment and research.
✕Less likely to help
Patients who are not involved in HIV treatment or research may not receive direct benefits from this conference.
What this research studies
This research involves a biennial conference that brings together healthcare professionals, researchers, and scientists to discuss the latest advancements in HIV and AIDS treatment. The conference aims to share knowledge on antiviral drug development, vaccine progress, and potential curative strategies. It also focuses on training young scientists and providing opportunities for underrepresented groups in the field. Participants will engage in workshops and discussions to enhance their understanding of HIV management.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and strategies for managing HIV, ultimately enhancing patient outcomes.
How similar studies have gone: Previous conferences and workshops in this field have successfully facilitated knowledge exchange and led to advancements in HIV treatment.
Where this research is happening
-
Emory University
Atlanta, United States Active
Researchers
- Principal investigator: Schinazi, Raymond Felix — Emory University
- Study coordinator: Schinazi, Raymond Felix
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.